EMA To Consider How To Deliver Drug Risks Information Via Digital Formats
Electronic Distribution Of Education Materials Cannot Substitute Paper Materials
Executive Summary
European Medicines Agency plans to finalize changes to its guideline on additional risk minimization measures and then establish a new drafting group on digitalization of education materials.
You may also be interested in...
EMA’s Revised Guide On Additional Risk Minimization ‘Overly Detailed’
Executive Summary: The European pharma industry federation believes the advice provided in the updated draft EU guideline on additional risk minimization measures is far too detailed, resulting in a lack of focus, information overlap and confusion.
EMA To Beef Up Guidance On Additional Risk Minimization Tools
Based on its experience of reviewing tools used by companies for additional risk minimization, the European Medicines Agency is planning to update its guidance on this topic with more information on how these tools can be better employed.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.